一项随机、双盲、安慰剂对照、平行组试验,旨在评估顺势疗法药物对慢性鼻窦炎的疗效

Praveen Oberai, S. Kaushik, Sunil Ramteke, M. Sinha, Sarabjit Sarkar, Kalpana Gautam, Arvind Kumar, Harleen Kaur, R. Manchanda, Roja Varanasi
{"title":"一项随机、双盲、安慰剂对照、平行组试验,旨在评估顺势疗法药物对慢性鼻窦炎的疗效","authors":"Praveen Oberai, S. Kaushik, Sunil Ramteke, M. Sinha, Sarabjit Sarkar, Kalpana Gautam, Arvind Kumar, Harleen Kaur, R. Manchanda, Roja Varanasi","doi":"10.53945/2320-7094.1225","DOIUrl":null,"url":null,"abstract":"Background: Chronic rhinosinusitis (CRS) is a significant health problem impacting health related quality of life. Objectives: This study assesses the efficacy of individualised homoeopathy (IH) in LM potency in CRS. Methods: A randomised, double-blind and placebo-controlled trial on patients with CRS was undertaken at four institutes, from July 2012 to December 2013. Eligible participants were randomised to IH in LMpotencies (n = 60) or a similar placebo (n = 60). Primary outcome was change in the total symptoms score (TSS) (area under the curve [AUC]) and in sinus nasal outcome test 22 over 3 months. Intention-totreat approach was used for analyses. Results: TSS AUC over 3 months was less in the homoeopathy group compared to the placebo group but was statistically insignificant (IH: 1303.1 ± 612.2; P = 1380.1 ± 811.8; 95% CI: −336.9, 182.9; P = 0.56). The absolute difference in TSS from baseline had a statistically significant difference at day 60 (mean difference = 4; 95% CI: 0.3–7.7, P = 0.03) and day 75 (mean difference =3.8; 95%: 0.1–7.5, P = 0.04) favouring homoeopathy. The global assessment by the investigator and patient showed satisfactory improvement at day 60 mean difference = 0.6, 95% CI: 0.27–0.86, P = 0.0001 and day 75 mean difference = 0.5, 95% CI: 0.27–0.84, P = 0.0001, respectively. A positive trend was observed in rhinoscopy score in homoeopathy group (mean difference: 0.9, 95% CI: −0.00–1.8, p=0.05). There was no difference in computed tomography scan scores of paranasal sinuses between the groups. Conclusion: This study provides a positive trend to support the effect of individually selected homoeopathic remedies in patients with CRS and warrants further evaluation. Acknowledgments and Source of Funding The authors are grateful to the participants who participated in the study. The radiologist for their viewing and assessing the CT scan films. The authors also acknowledge, the contribution of ENT consultants engaged in the assessment of the enrolled patients. Funding: This study was funded by Central Council for Research in Homoeopathy Authors Praveen Oberai, Subhash Kaushik, Sunil Ramteke, M N. Sinha, Sarabjit Sarkar, Kalpana Gautam, Arvind Kumar, Harleen Kaur, Raj Kumar Manchanda, and Roja Varanasi This original article is available in Indian Journal of Research in Homoeopathy: https://ijrh.researchcommons.org/ journal/vol17/iss1/3","PeriodicalId":13469,"journal":{"name":"Indian Journal of Research in Homoeopathy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"A randomised, double-blind, placebo-controlled and parallel-arm trial to assess the effect of homoeopathic medicines on chronic rhinosinusitis\",\"authors\":\"Praveen Oberai, S. Kaushik, Sunil Ramteke, M. Sinha, Sarabjit Sarkar, Kalpana Gautam, Arvind Kumar, Harleen Kaur, R. Manchanda, Roja Varanasi\",\"doi\":\"10.53945/2320-7094.1225\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Chronic rhinosinusitis (CRS) is a significant health problem impacting health related quality of life. Objectives: This study assesses the efficacy of individualised homoeopathy (IH) in LM potency in CRS. Methods: A randomised, double-blind and placebo-controlled trial on patients with CRS was undertaken at four institutes, from July 2012 to December 2013. Eligible participants were randomised to IH in LMpotencies (n = 60) or a similar placebo (n = 60). Primary outcome was change in the total symptoms score (TSS) (area under the curve [AUC]) and in sinus nasal outcome test 22 over 3 months. Intention-totreat approach was used for analyses. Results: TSS AUC over 3 months was less in the homoeopathy group compared to the placebo group but was statistically insignificant (IH: 1303.1 ± 612.2; P = 1380.1 ± 811.8; 95% CI: −336.9, 182.9; P = 0.56). The absolute difference in TSS from baseline had a statistically significant difference at day 60 (mean difference = 4; 95% CI: 0.3–7.7, P = 0.03) and day 75 (mean difference =3.8; 95%: 0.1–7.5, P = 0.04) favouring homoeopathy. The global assessment by the investigator and patient showed satisfactory improvement at day 60 mean difference = 0.6, 95% CI: 0.27–0.86, P = 0.0001 and day 75 mean difference = 0.5, 95% CI: 0.27–0.84, P = 0.0001, respectively. A positive trend was observed in rhinoscopy score in homoeopathy group (mean difference: 0.9, 95% CI: −0.00–1.8, p=0.05). There was no difference in computed tomography scan scores of paranasal sinuses between the groups. Conclusion: This study provides a positive trend to support the effect of individually selected homoeopathic remedies in patients with CRS and warrants further evaluation. Acknowledgments and Source of Funding The authors are grateful to the participants who participated in the study. The radiologist for their viewing and assessing the CT scan films. The authors also acknowledge, the contribution of ENT consultants engaged in the assessment of the enrolled patients. Funding: This study was funded by Central Council for Research in Homoeopathy Authors Praveen Oberai, Subhash Kaushik, Sunil Ramteke, M N. Sinha, Sarabjit Sarkar, Kalpana Gautam, Arvind Kumar, Harleen Kaur, Raj Kumar Manchanda, and Roja Varanasi This original article is available in Indian Journal of Research in Homoeopathy: https://ijrh.researchcommons.org/ journal/vol17/iss1/3\",\"PeriodicalId\":13469,\"journal\":{\"name\":\"Indian Journal of Research in Homoeopathy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Indian Journal of Research in Homoeopathy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.53945/2320-7094.1225\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Research in Homoeopathy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53945/2320-7094.1225","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

摘要

背景:慢性鼻窦炎(CRS)是影响健康相关生活质量的重要健康问题。目的:本研究评估个体化顺势疗法(IH)对CRS患者LM效价的影响。方法:2012年7月至2013年12月,在4个研究所对CRS患者进行随机、双盲、安慰剂对照试验。符合条件的参与者被随机分配到IH组(n = 60)或类似的安慰剂组(n = 60)。主要转归是3个月内总症状评分(TSS)(曲线下面积[AUC])和鼻窦预后试验22的变化。采用意向治疗法进行分析。结果:顺势疗法组3个月TSS AUC低于安慰剂组,但差异无统计学意义(IH: 1303.1±612.2;P = 1380.1±811.8;95% ci:−336.9,182.9;P = 0.56)。TSS与基线的绝对差值在第60天有统计学意义(平均差值= 4;95% CI: 0.3-7.7, P = 0.03)和第75天(平均差值=3.8;95%: 0.1 ~ 7.5, P = 0.04)倾向顺势疗法。研究者和患者的总体评估显示,60天的平均差值= 0.6,95% CI: 0.27-0.86, P = 0.0001; 75天的平均差值= 0.5,95% CI: 0.27-0.84, P = 0.0001。顺势疗法组鼻内镜评分呈阳性趋势(平均差异:0.9,95% CI:−0.00 ~ 1.8,p=0.05)。两组间鼻窦计算机断层扫描评分无差异。结论:本研究为单独选择顺势疗法治疗CRS患者提供了积极的趋势,值得进一步评估。致谢和资金来源作者感谢参与本研究的参与者。放射科医生观看和评估CT扫描片。作者也承认,耳鼻喉科顾问参与评估入组患者的贡献。本研究由顺势疗法研究中央委员会资助,作者Praveen Oberai, Subhash Kaushik, Sunil Ramteke, M N. Sinha, Sarabjit Sarkar, Kalpana Gautam, Arvind Kumar, Harleen Kaur, Raj Kumar Manchanda和Roja Varanasi。本文原文发表于印度顺势疗法研究杂志:https://ijrh.researchcommons.org/ Journal /vol17/iss1/3
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
A randomised, double-blind, placebo-controlled and parallel-arm trial to assess the effect of homoeopathic medicines on chronic rhinosinusitis
Background: Chronic rhinosinusitis (CRS) is a significant health problem impacting health related quality of life. Objectives: This study assesses the efficacy of individualised homoeopathy (IH) in LM potency in CRS. Methods: A randomised, double-blind and placebo-controlled trial on patients with CRS was undertaken at four institutes, from July 2012 to December 2013. Eligible participants were randomised to IH in LMpotencies (n = 60) or a similar placebo (n = 60). Primary outcome was change in the total symptoms score (TSS) (area under the curve [AUC]) and in sinus nasal outcome test 22 over 3 months. Intention-totreat approach was used for analyses. Results: TSS AUC over 3 months was less in the homoeopathy group compared to the placebo group but was statistically insignificant (IH: 1303.1 ± 612.2; P = 1380.1 ± 811.8; 95% CI: −336.9, 182.9; P = 0.56). The absolute difference in TSS from baseline had a statistically significant difference at day 60 (mean difference = 4; 95% CI: 0.3–7.7, P = 0.03) and day 75 (mean difference =3.8; 95%: 0.1–7.5, P = 0.04) favouring homoeopathy. The global assessment by the investigator and patient showed satisfactory improvement at day 60 mean difference = 0.6, 95% CI: 0.27–0.86, P = 0.0001 and day 75 mean difference = 0.5, 95% CI: 0.27–0.84, P = 0.0001, respectively. A positive trend was observed in rhinoscopy score in homoeopathy group (mean difference: 0.9, 95% CI: −0.00–1.8, p=0.05). There was no difference in computed tomography scan scores of paranasal sinuses between the groups. Conclusion: This study provides a positive trend to support the effect of individually selected homoeopathic remedies in patients with CRS and warrants further evaluation. Acknowledgments and Source of Funding The authors are grateful to the participants who participated in the study. The radiologist for their viewing and assessing the CT scan films. The authors also acknowledge, the contribution of ENT consultants engaged in the assessment of the enrolled patients. Funding: This study was funded by Central Council for Research in Homoeopathy Authors Praveen Oberai, Subhash Kaushik, Sunil Ramteke, M N. Sinha, Sarabjit Sarkar, Kalpana Gautam, Arvind Kumar, Harleen Kaur, Raj Kumar Manchanda, and Roja Varanasi This original article is available in Indian Journal of Research in Homoeopathy: https://ijrh.researchcommons.org/ journal/vol17/iss1/3
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Indian Journal of Research in Homoeopathy
Indian Journal of Research in Homoeopathy Medicine-Complementary and Alternative Medicine
CiteScore
1.60
自引率
0.00%
发文量
33
审稿时长
16 weeks
期刊最新文献
Safety of potentised dilutions of Rhus toxicodendron in Wistar albino rats Obstinate chronic venous ulcer treated with the homoeopathic medicine Silicea: A case report 269 years of Homoeopathy: The healing continues Homoeopathic treatment of a child with internet gaming disorder and atopic dermatitis: A case report Tinea cruris managed with a single dose of individualised homoeopathic medicine: A case report
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1